In vitro experiments have demonstrated that VEGF binding to Aβ-40 and Aβ-42 within the amyloid plaques in the brain of AD patients might result in sequestration and local deficiency of available VEGF and, subsequently, contribute to insufficient vascularisation and reduced cerebral perfusion16–18. The gene discussed is VEGFA; the disease is Alzheimer disease.